AVM Biotech
Director of the Immunotherapy Program at the University of North Carolina Lineberger Comprehensive Cancer Center and professor in the Department of Microbiology and Immunology at University of North Carolina at Chapel Hill. He received his medical degree from the University of Milan in Italy, with further training in hematology from the University of Parma and a post-doctoral fellowship from Baylor College of Medicine in Houston, Texas.
This person is not in the org chart
This person is not in any offices
AVM Biotech
5 followers
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.